Close  

Brazil set to test Chinese coronavirus vaccine

/ 10:52 AM July 21, 2020

SAO PAULO — Brazil will begin advanced clinical testing of a Chinese-made vaccine against the new coronavirus Tuesday, issuing the first doses to around 900 volunteers, officials said.

ADVERTISEMENT

The coronavirus vaccine, developed by private Chinese pharmaceutical firm Sinovac, is the third in the world to enter Phase 3 trials, or large-scale testing on humans — the last step before regulatory approval.

It will be administered to doctors and other health workers who volunteer for the program across six states in Brazil, one of the countries hit hardest by the pandemic.

FEATURED STORIES

“Trials of CoronaVac, one of the vaccines that has advanced furthest in testing in the world, will begin at the Clinical Hospital of Sao Paulo,” the state’s governor, Joao Doria, told a news conference.

He said initial results were expected within 90 days.

Sinovac is partnering with a Brazilian public health research center, the Butantan Institute, on the trials.

If the vaccine proves safe and effective, the institute will have the right to produce 120 million doses under the deal, according to officials.

“In Brazil, we could have the first vaccine to be put to widespread use, which is very, very promising,” said the head of the Butantan Institute, Dimas Covas.

In this file photo taken on March 26, 2020, a researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil. Brazil is in the forefront of vaccines for the new coronavirus, testing in large scale and preparing for the production of millions of dosis.  Photo by Douglas MAGNO / AFP

Brazil is the second-hardest-hit country in the coronavirus pandemic, after the United States.

Its death toll surpassed 80,000 on Monday, and it has registered 2.1 million infections.

ADVERTISEMENT

Those grim figures make it an ideal testing ground for potential vaccines, since the virus is still spreading quickly.

Brazil is also helping carry out Phase 3 testing of another experimental vaccine, developed by Oxford University in Britain and pharmaceutical firm AstraZeneca.

Another vaccine, developed by state-owned Chinese company Sinopharm, also entered Phase 3 trials this month in the United Arab Emirates.

They are the three most advanced of the dozens of projects worldwide by scientists racing to develop and test a vaccine against the new virus.

A fourth, existing vaccine against tuberculosis is also in Phase 3 trials in Australia as a potential coronavirus immunization.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Brazil, Chinese vaccine, coronavirus pandemic, coronavirus vaccine, COVID-19, COVID-19 death toll, COVID-19 vaccine clinical trials, Sao Paulo
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.